Citation 2039

MAI,LP: GUERITTE,F: DUMONTET,V: TRI, MV: HILL,B: THOISON,O: GUENARD,D: SEVENET,T:. (2001). CYTOTOXICITY OF RHAMNOSYLANTHRAQUINONES AND RHAMNOSYLANTHRONES FROM RHAMNUS NEPALENIS.. 64(9)

Citation Details

Title	CYTOTOXICITY OF RHAMNOSYLANTHRAQUINONES AND RHAMNOSYLANTHRONES FROM RHAMNUS NEPALENIS.
Authors	MAI,LP: GUERITTE,F: DUMONTET,V: TRI, MV: HILL,B: THOISON,O: GUENARD,D: SEVENET,T:
Year	2001
Volume	64
Issue	9

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Rhamnus nepalensis (RHAMNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHRYSOPHANIC ACID	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHRYSOPHANIC ACID	INACTIVE
3	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PHYSCION	None
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PHYSCION	INACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHRYSOPHANIC ACID BIANTHRONE 5-A	None
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHRYSOPHANIC ACID BIANTHRONE 5-A	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHRYSOPHANIC ACID BIANTHRONE 5-3	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHRYSOPHANIC ACID BIANTHRONE 5-3	ACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EMODIN	None
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EMODIN	INACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EMODIN ANTHRONE	None
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EMODIN ANTHRONE	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OF	CHRYSOPHANIC ACID-EMODIN-BIANTHRONE 6-A	None
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHRYSOPHANIC ACID-EMODIN-BIANTHRONE 6-A	ACTIVE
15	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHRYSOPHANIC ACID-EMODIN-BIANTHRONE 6-B	None
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHRYSOPHANIC ACID-EMODIN-BIANTHRONE 6-B	ACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EMODIN BIANTHRONE 7-A	None
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EMODIN BIANTHRONE 7-A	ACTIVE
19	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EMODIN BIANTHRONE 7-B	None
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EMODIN BIANTHRONE 7-B	ACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PRINOIDIN	None
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PRINOIDIN	STRONG ACTIVITY
23	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PRINOIDIN	ACTIVE
24	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PRINOIDIN	INACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FRANGULIN A,2'-3'-DI-O-ACETYL:	None
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FRANGULIN A,2'-3'-DI-O-ACETYL:	ACTIVE
27	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PRINOIDIN-EMODIN-BIANTHRONE 9-A	None
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PRINOIDIN-EMODIN-BIANTHRONE 9-A	ACTIVE
29	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PRINOIDIN-EMODIN-BIANTHRONE 9-B	None
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PRINOIDIN-EMODIN-BIANTHRONE 9-B	ACTIVE
31	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PRINOIDIN-EMODIN-BIANTHRONE 9-C	None
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PRINOIDIN-EMODIN-BIANTHRONE 9-C	ACTIVE
33	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PRINOIDIN-EMOIDIN-BIANTHRONE 9-D	None
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PRINOIDIN-EMOIDIN-BIANTHRONE 9-D	ACTIVE
35	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FRANGULIN A,2'-O-ACETYL:	None
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FRANGULIN A,2'-O-ACETYL:	INACTIVE
37	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PRINOIDIN BIANTHRONE 10-A	None
38	CYTOTOXIC ACTIVITY	ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PRINOIDIN BIANTHRONE 10-A	ACTIVE
39	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PRINOIDIN BIANTHRONE 10-B	None
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PRINOIDIN BIANTHRONE 10-B	ACTIVE
41	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RHAMNEPALIN 11-A	None
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHAMNEPALIN 11-A	ACTIVE
43	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RHAMNEPALIN 11-B	None
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHAMNEPALIN 11-B	ACTIVE
45	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RHAMNEPALIN 11-6	None
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHAMNEPALIN 11-6	ACTIVE

Citation 2039

Citation Details

Summary

Organisms and Their Experiments (1)

Rhamnus nepalensis (RHAMNACEAE)

Show SPARQL Queries (1)

Query 1